JAMES HAWKINS - 07 Dec 2023 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ James B. Hawkins
Issuer symbol
IRMD
Transactions as of
07 Dec 2023
Transactions value $
$0
Form type
4
Filing time
11 Dec 2023, 18:00:08 UTC
Previous filing
05 Dec 2023
Next filing
14 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +1,036 +2.83% 37,598 07 Dec 2023 Direct F1
transaction IRMD Common Stock Options Exercise +1,750 +4.65% 39,348 07 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -1,036 -100% $0.000000* 0 07 Dec 2023 Common Stock 1,036 Direct F1, F2
transaction IRMD Restricted Stock Units Options Exercise $0 -1,750 -50% $0.000000 1,751 07 Dec 2023 Common Stock 1,750 Direct F1, F3
transaction IRMD Restricted Stock Units Award $0 +2,393 +137% $0.000000 4,144 07 Dec 2023 Common Stock 2,393 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On December 7, 2021, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F3 On December 7, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F4 On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.